Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Nanning Pangbo Biological Engineering is a Chinese bioenzyme company focused on the R&D, manufacturing, sales, and technical support of food-grade and pharmaceutical-grade enzyme preparations. The company is best known for high-activity papain, bromelain, lysozyme, lactase, nattokinase, transglutaminase, digestive enzymes, and other plant-, microbial-, and animal-derived enzyme products. Its products are used across food processing, dietary supplements, pharmaceutical and health products, feed, cleaning, and related industrial applications rather than a traditional therapeutic drug pipeline. Pangbo appears to operate as a commercial-stage enzyme manufacturer with in-house production and application development capabilities, and it exports to multiple international markets. Publicly available information suggests it is one of the larger specialized enzyme producers in China, particularly in papain and bromelain.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Nanning Pangbo Biological Engineering.